Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.83%
0%
-13.83%
6 Months
-28.95%
0%
-28.95%
1 Year
62.0%
0%
62.0%
2 Years
24.62%
0%
24.62%
3 Years
-36.22%
0%
-36.22%
4 Years
-33.06%
0%
-33.06%
5 Years
-50.91%
0%
-50.91%
King International Investment Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-8.57%
EBIT Growth (5y)
-181.47%
EBIT to Interest (avg)
-8.54
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.55
Tax Ratio
35.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.20%
ROE (avg)
0.93%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
0.65
EV to EBIT
13.23
EV to EBITDA
11.53
EV to Capital Employed
0.65
EV to Sales
0.94
PEG Ratio
0.10
Dividend Yield
NA
ROCE (Latest)
4.91%
ROE (Latest)
4.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2021
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Mar'23
Mar'23
Mar'22
Change(%)
Net Sales
223.90
92.90
141.01%
Operating Profit (PBDIT) excl Other Income
-28.50
-21.00
-35.71%
Interest
0.20
0.00
Exceptional Items
1.20
-9.10
113.19%
Consolidate Net Profit
-31.80
-37.30
14.75%
Operating Profit Margin (Excl OI)
-145.30%
-242.90%
9.76%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2023 is 141.01% vs -8.92% in Mar 2022
Consolidated Net Profit
YoY Growth in year ended Mar 2023 is 14.75% vs -1,521.74% in Mar 2022
About King International Investment Ltd. 
King International Investment Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






